Navigation Links
Codexis and Chemtex to Collaborate on Sustainable Detergent Alcohols for the Household Products Market
Date:7/28/2011

REDWOOD CITY, Calif. and TORTONA, Italy, July 28, 2011 /PRNewswire/ -- Codexis, Inc. (Nasdaq: CDXS) and Chemtex, a global technology and engineering Company wholly-owned by Italy's Gruppo Mossi & Ghisolfi ("M&G Group"), today announced a broad collaboration to develop and produce sustainable detergent alcohols for use in the household products market.  The collaboration includes development of second generation detergent alcohols from cellulosic (non-food) biomass.

Detergent alcohols - a $6 billion worldwide market – are surfactants which stabilize mixtures of oil and water.  They are widely used in laundry detergents, shampoos and other consumer products.  Detergent alcohols today are made from non-sustainable palm kernel and petroleum sources.

The collaboration with Chemtex includes the following:


  • Development of a world-class process for the conversion of cellulosic biomass to sustainable detergent alcohols

  • The process will utilize Chemtex's break-through PROESA™ Pretreatment and Viscosity Reduction Technology with Codexis' proprietary CodeEvolver™ directed evolution technology to enable more cost-effective production of detergent alcohols from cellulosic feedstocks. Both elements—an efficient pretreatment and high performance enzymes—are required to enable commercial use of cellulosic feedstocks such as straw, sugar cane bagasse and energy crops to produce industrial products.  The collaboration will focus on development of a technology package suitable for use with a wide variety of feedstocks.  Under the terms of the agreement, Codexis will have exclusive rights to PROESA™ technology for the production of detergent alcohols.


  • Scale up of second generation detergent alcohols

  • Cellulosic sugars will be converted to de
    '/>"/>

    SOURCE Codexis, Inc.
    Copyright©2010 PR Newswire.
    All rights reserved

    Page: 1 2 3 4

    Related medicine technology :

    1. Codexis to Present at the Pacific Crest and Canaccord Genuity Conferences
    2. Codexis to Present at 3 Investor Conferences in June
    3. Codexis Achieves Development Milestones With Teva
    4. Codexis to Present at Barclays Conference
    5. Codexis to Announce First Quarter 2011 Financial Results on May 5, 2011
    6. Codexis Names Jacques Beaudry-Losique VP Corporate Development & Strategy
    7. Codexis Announces Carbon Capture Progress at ARPA-E Summit
    8. Codexis Names David Anton CTO & SVP, Process Development & Manufacturing
    9. Codexis to Present at the Jefferies and Pacific Crest Conferences
    10. Codexis Signs First Japanese Biocatalysis Collaboration With Dainippon Sumitomo Pharma
    11. Codexis to Announce Fourth Quarter 2010 Financial Results on February 3, 2011
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:7/24/2014)... 24, 2014  Kinex Pharmaceuticals announced the receipt of ... KX2-391 Ointment for the commencement of a Phase I ... third IND to be allowed by the US FDA ... a synthetic, orally active and highly selective inhibitor of ... the induction of p53, G2/M arrest of proliferating cell ...
    (Date:7/24/2014)... 2014 Consolidated Net Profit increased by 43.65 ...   , India Business grew by 20.87% to Rs. ... 4,886.70 Mn Rest of World (ROW) Business grew by ... by 34.53% to Rs. 977.26 Mn Latin America Business ... Glenmark Pharmaceuticals Limited, the research-led global integrated pharmaceutical company, today ...
    (Date:7/24/2014)... 2014 Boston Children,s Hospital,s Global Pediatric Summit ... feature an "Innovation Tank" – a forum designed to ... their business or product solution to a panel of ... how to accelerate the innovation and bring it to ... Friday, October 31, will be moderated by Daymond ...
    Breaking Medicine Technology:Kinex Pharmaceuticals Announces Allowance of the Investigational New Drug (IND) application for KX2-391 Ointment by the United States Food and Drug Administration (FDA) 2Kinex Pharmaceuticals Announces Allowance of the Investigational New Drug (IND) application for KX2-391 Ointment by the United States Food and Drug Administration (FDA) 3Kinex Pharmaceuticals Announces Allowance of the Investigational New Drug (IND) application for KX2-391 Ointment by the United States Food and Drug Administration (FDA) 4Glenmark's Consolidated Revenue Increases by 20.08% to Rs. 14,869.40 Mn for Q1 FY 14 - 15 2Glenmark's Consolidated Revenue Increases by 20.08% to Rs. 14,869.40 Mn for Q1 FY 14 - 15 3Glenmark's Consolidated Revenue Increases by 20.08% to Rs. 14,869.40 Mn for Q1 FY 14 - 15 4Taking on Tomorrow to Feature "Innovation Tank" Pitch Opportunity for Aspiring Pediatric Health Care Entrepreneurs 2Taking on Tomorrow to Feature "Innovation Tank" Pitch Opportunity for Aspiring Pediatric Health Care Entrepreneurs 3
    ... July 12, 2011 Vapotherm, a privately held manufacturer of ... that it has signed a new exclusive distribution agreement with ... Korea for the Vapotherm acute care product line. ... Hippo to bring high flow therapy to the Korean market," ...
    ... 12, 2011 UBM TechInsights, the leader in technical ... announced today that medical devices industry veteran Bill Betten ... Devices.  In this role Mr. Betten will draw upon ... medical device sector maximize the effectiveness of the product ...
    Cached Medicine Technology:Vapotherm Announces New Exclusive Distribution Agreement with Hippo Medical for South Korea 2UBM TechInsights Hires Medical Devices Industry Veteran Bill Betten 2
    (Date:7/25/2014)... Tampa, FL (PRWEB) July 25, 2014 ... launches their innovative toothbrushes with antibacterial silver that naturally kill ... land on the brush. , A toothbrush is the ... diseases, dental health and hygiene, however, it is subject to ... the air. , There are more bacteria in the mouth ...
    (Date:7/24/2014)... 2014 Dr. Henry H. Ting, a ... has been appointed senior vice president and chief quality ... his new role, he will oversee the hospital's clinical ... successfully led quality initiatives and interprofessional teams at the ... for the Door-to-Balloon Alliance, a collaboration of more than ...
    (Date:7/24/2014)... to light at night, which shuts off nighttime production ... to tamoxifen, a widely used breast cancer drug, says ... cancer researchers. The study, "Circadian and Melatonin Disruption by ... Tamoxifen Therapy in Breast Cancer," published in the journal ... that melatonin is vital to the success of tamoxifen ...
    (Date:7/24/2014)... Park, NC (PRWEB) July 24, 2014 ... ethnic minorities, and low-income households are disproportionately affected ... public food safety net in the United States, ... , Under Section 743 of the Consolidated Appropriations ... Department of Agriculture's Food and Nutrition Service (FNS) ...
    (Date:7/24/2014)... Monica, CA (PRWEB) July 24, 2014 ... health seriously, they must consider their own financial and ... flabby and weak marketing campaigns to the next level ... CallFire’s Cloud Call Center, IVR, Voice Broadcast, Call Tracking ... than a 98% open rate, text messages are quickly ...
    Breaking Medicine News(10 mins):Health News:Silver®Care’s New Silver Antibacterial Toothbrushes Naturally Kill Oral Germs 2Health News:Silver®Care’s New Silver Antibacterial Toothbrushes Naturally Kill Oral Germs 3Health News:NewYork-Presbyterian Hospital Names New Senior Vice President for Quality and Patient Safety 2Health News:NewYork-Presbyterian Hospital Names New Senior Vice President for Quality and Patient Safety 3Health News:Total darkness at night is key to success of breast cancer therapy -- Tulane study 2Health News:Report: Vulnerable Populations Disproportionately Affected by Food Security, Despite Public Programs 2Health News:Report: Vulnerable Populations Disproportionately Affected by Food Security, Despite Public Programs 3Health News:Pump Up Your Gym’s Marketing Muscles with Mobile Marketing: CallFire's Health & Fitness Webinar Week – July 28th to August 1st 2Health News:Pump Up Your Gym’s Marketing Muscles with Mobile Marketing: CallFire's Health & Fitness Webinar Week – July 28th to August 1st 3
    ... that a new strain of E. coli O157was responsible for ... in Europe and Australia, but is apparently very rare in ... the laboratory from other types of E.coli O157 and this ... it,' said HPS consultant Dr John Cowden. 'It produces the ...
    ... In a bid to save its plummeting sales of chicken ... //The campaign would ensure that the customers get ... been planned by McDonald’s Corp., of Oakbrook, Ill. , ... ensure that is a epidemic and bird flu scare spread ...
    ... study that was published in Urology Journal BJUI International has ... and almost half of 19-year-olds who have a problem are ... the Chinese University of Hong Kong and the Prince of ... questionnaires surveying children who were aged 5 to 19. The ...
    ... popular drug for depression has been studied by researchers, in ... from the Cold Spring Harbor Laboratory// in Long Island, New ... immature brain cells. ,This could pave the way ... Alzheimer's. The researchers, as part of their study, analyzed proteins ...
    ... 2007, cigarette packets will carry graphic representations depicting the dangerous ... ward off the smoking habit. The pictorial representation could be ... womb. ,A website installed by the Department of Health, ... range of pictures that intend to underline the pitfalls of ...
    ... is a private company and was set up in 1994 in ... accepted to provide health care facility// free of cost to NHS ... General Practitioners for 7,000 patients and employ 3 doctors and 7 ... in London. ,The deal has been signed by ...
    Cached Medicine News:
    ... a broad selection of tip styles ... of ophthalmic procedures. Each single use ... a safety cap to lock switch ... not in use, and carries a ...
    ... Accu-Temp Cauteries provide a broad ... in a wide variety of ophthalmic ... packaged sterile, complete with a safety ... "off " position when not in ...
    ... The Luminary LASIK Light Probes provide ... that allows the corneal interface to be ... use of the Tindal effect and light ... of interface debris, epithelial deposits, flap edge ...
    ... EEG system designed to satisfy the needs ... center. Ready to use, Comet XL is ... and Photic Stimulator. Select from various mobile ... your individual needs. These powerful, easy-to-use EEG ...
    Medicine Products: